David Rabuka
Principal investigator, leads ACRIGEN BIOSCIENCES, INC. and REDWOOD BIOSCIENCE INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 24, 2022 | NSF | SBIR Phase II SBIR Phase II: Development of a safe gene editing system via CRISPR-Cas and Cas inhibitor co-delivery | $1.0M | ACRIGEN BIOSCIENCES, INC. |
| Feb 15, 2022 | NIH | SBIR Phase I Enhancing CRISPR-mediated homology-directed repair using anti-CRISPR proteins | $257K | ACRIGEN BIOSCIENCES, INC. |
| Apr 19, 2021 | NIH | STTR Phase I Development of Safe in Utero Gene Editing Technology in Mice | $257K | ACRIGEN BIOSCIENCES, INC. |
| Sep 9, 2020 | NSF | SBIR Phase I SBIR Phase I: Development of a safe gene editing system via CRISPR-Cas and Cas inhibitor co-delivery | $225K | ACRIGEN BIOSCIENCES, INC. |
| Apr 2, 2020 | NIH | SBIR Phase I Discovery and applications of CRISPR-Cas inhibitor proteins | $252K | ACRIGEN BIOSCIENCES, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,052
Awards as PI#417
Patents#273
Companies
- ACRIGEN BIOSCIENCES, INC.Leads (SEC Form D) · Biotech
- REDWOOD BIOSCIENCE INCLeads (SEC Form D)
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.